Related Experiment Video
Updated: Jun 20, 2026
Optimization of a Quantitative Micro-neutralization Assay
Published on: December 14, 2016
Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies
Sunil R Vaidya1, David W G Brown, Li Jin
1Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK. Sunil.Vaidya@hpa.org.uk
Abstract:
Although the plaque reduction neutralization test (PRNT) is considered the "gold-standard" assay for measuring neutralizing antibodies for mumps, it is technically demanding, slow and requires large serum volumes, which limits its use for investigating mumps vaccine efficacy and population susceptibility. Therefore, an immunocolourimetric-based focus reduction neutralization test (FRNT) was developed and validated against PRNT using 30 blood donor plasma samples (16 positive, 5 equivocal, and 9 negative for mumps IgG by EIA). The samples were tested in triplicate by FRNT and PRNT in 10 and 4 separate assay runs, respectively, and 50% neutralizing antibody titres calculated using the Kärber formula. There was good correlation between the two neutralization assays (R(2)=0.88). Inter-assay variation for FRNT titres was 2-fold, compared to a 3-fold variation for PRNT titres. From the distribution of results, a positive cut-off for FRNT was defined as 1:4. In conclusion, FRNT has similar sensitivity to the PRNT and offers the advantage of speed (2 days vs. 7 days), reduced sample volume (40 microL vs. 150 microL), and the possibility of automation using 96-well plates. FRNT appears to be a good substitute for PRNT for characterising the immune response to mumps and for vaccine efficacy studies.
Insights
A new immunocolourimetric focus reduction neutralization test (FRNT) offers a faster, more efficient alternative to the plaque reduction neutralization test (PRNT) for measuring mumps neutralizing antibodies. This validated assay aids in evaluating mumps vaccine efficacy and population immunity.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- The plaque reduction neutralization test (PRNT) is the gold standard for mumps neutralizing antibodies but is labor-intensive and requires large serum volumes.
- These limitations hinder its application in large-scale studies of mumps vaccine efficacy and population susceptibility.
Purpose of the Study:
- To develop and validate an immunocolourimetric focus reduction neutralization test (FRNT) as a more accessible alternative to PRNT.
- To assess the correlation and performance of FRNT compared to PRNT for mumps antibody detection.
Main Methods:
- An immunocolourimetric FRNT was developed and validated against PRNT using 30 plasma samples.
- Samples were tested in triplicate, and 50% neutralizing antibody titers were calculated using the Kärber formula.
- Correlation (R²=0.88) and inter-assay variation (2-fold for FRNT, 3-fold for PRNT) were analyzed.
Main Results:
- FRNT demonstrated good correlation with PRNT.
- FRNT exhibited lower inter-assay variation compared to PRNT.
- A positive cut-off for FRNT was established at a 1:4 dilution.
Conclusions:
- FRNT is a sensitive and reliable assay for measuring mumps neutralizing antibodies.
- FRNT offers significant advantages over PRNT, including speed, reduced sample volume, and potential for automation.
- FRNT is a suitable substitute for PRNT in characterizing immune responses and evaluating mumps vaccine efficacy.
